118 related articles for article (PubMed ID: 1824499)
1. [Interaction between LDL receptor and lipoproteins containing apo B].
Clavey V; Agnani G; Bard JM; Lestavel-Delattre S; Fruchart JC
Ann Endocrinol (Paris); 1991; 52(6):459-63. PubMed ID: 1824499
[TBL] [Abstract][Full Text] [Related]
2. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells.
Agnani G; Bard JM; Candelier L; Delattre S; Fruchart JC; Clavey V
Arterioscler Thromb; 1991; 11(4):1021-9. PubMed ID: 2065026
[TBL] [Abstract][Full Text] [Related]
3. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E.
Clavey V; Lestavel-Delattre S; Copin C; Bard JM; Fruchart JC
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):963-71. PubMed ID: 7600129
[TBL] [Abstract][Full Text] [Related]
4. [The important role of apolipoprotein C-III in lipoprotein metabolism].
Fruchart JC; Duriez P
C R Seances Soc Biol Fil; 1995; 189(5):889-97. PubMed ID: 8673634
[TBL] [Abstract][Full Text] [Related]
5. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
6. Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype.
Luc G; Ducimetiere P; Bard JM; Arveiler D; Evans A; Cambien F; Fruchart JC; Fievet C
Atherosclerosis; 1997 Jun; 131(2):257-62. PubMed ID: 9199280
[TBL] [Abstract][Full Text] [Related]
7. Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism.
Starck M; Schiele F; Herbeth B; Vincent-Viry M; Beaud B; Siest G; Visvikis S
Atherosclerosis; 2001 Apr; 155(2):509-16. PubMed ID: 11254923
[TBL] [Abstract][Full Text] [Related]
8. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
Chappell DA
J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
[TBL] [Abstract][Full Text] [Related]
9. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
Demant T; Bedford D; Packard CJ; Shepherd J
J Clin Invest; 1991 Nov; 88(5):1490-501. PubMed ID: 1939641
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
11. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.
Sehayek E; Lewin-Velvert U; Chajek-Shaul T; Eisenberg S
J Clin Invest; 1991 Aug; 88(2):553-60. PubMed ID: 1864965
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact.
Gylling H; Kontula K; Koivisto UM; Miettinen HE; Miettinen TA
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):38-44. PubMed ID: 9012635
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of the apolipoprotein E receptor from canine and human liver.
Hui DY; Brecht WJ; Hall EA; Friedman G; Innerarity TL; Mahley RW
J Biol Chem; 1986 Mar; 261(9):4256-67. PubMed ID: 3005328
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein heterogeneity and its effect on apolipoprotein assays.
Fruchart JC
Scand J Clin Lab Invest Suppl; 1990; 198():51-7. PubMed ID: 2111936
[TBL] [Abstract][Full Text] [Related]
16. Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor.
Chen Z; Saffitz JE; Latour MA; Schonfeld G
J Clin Invest; 1999 May; 103(10):1419-30. PubMed ID: 10330424
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
[TBL] [Abstract][Full Text] [Related]
18. Effect of exogenous apo E on the cellular binding of lipoproteins.
Mokuno H; Ishibashi S; Shimano H; Gothoda T; Takaku F; Yamada N
Gerontology; 1990; 36 Suppl 1():42-8. PubMed ID: 2384229
[TBL] [Abstract][Full Text] [Related]
19. Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits.
Yamada N; Shames DM; Havel RJ
J Clin Invest; 1987 Aug; 80(2):507-15. PubMed ID: 3611356
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.
Yamashita S; Sprecher DL; Sakai N; Matsuzawa Y; Tarui S; Hui DY
J Clin Invest; 1990 Sep; 86(3):688-95. PubMed ID: 2118552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
